| Nov 15 |
Insider Buys Additional US$100k In Immunic Stock
|
| Nov 14 |
Immunic announces publication of IMU-856 data
|
| Nov 13 |
Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology
|
| Nov 9 |
Immunic, Inc. (IMUX) Q3 2024 Earnings Call Transcript
|
| Nov 9 |
Immunic Inc (IMUX) Q3 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges
|
| Nov 9 |
Immunic, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 7 |
Immunic: Q3 Earnings Snapshot
|
| Nov 7 |
Immunic GAAP EPS of -$0.24 misses by $0.02
|
| Nov 7 |
Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Nov 6 |
Immunic Q3 2024 Earnings Preview
|
